← Leaderboards
Herbert Yu
Louisiana State Univ Hsc Shreveport
$10,685,253
Attributed
$13,209,748
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$13,209,748 · 6
By mechanism
R01$9,457,326 · 3
U01$3,435,575 · 1
P30$235,427 · 1
R03$81,420 · 1
Top collaborators
- Lopa Mishra5 shared
- Kirti Shetty5 shared
- Shulin Li3 shared
- Linda M S Resar2 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsRaceObesityEtiologyCancer RiskPrimary Carcinoma Of The Liver CellsRisk FactorsGeneticPlayDietPhysical ActivityLife StyleGene Environment InteractionApoptosisDisease OutcomeIncidenceEnvironmentMemberAffectBaseLifestyle FactorsGenetic Predisposition To DiseaseQuestionnairesArea
Grant awards (24)
Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer$760,961
U01 · FY2022 · CA
Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer$652,359
U01 · FY2021 · CA
Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer$663,918
U01 · FY2020 · CA
Population Sciences in the Pacific$81,718
P30 · FY2020 · CA · contact PI
Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer$647,886
U01 · FY2019 · CA
Population Sciences in the Pacific$81,169
P30 · FY2019 · CA · contact PI
Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer$710,451
U01 · FY2018 · CA
Population Sciences in the Pacific$72,540
P30 · FY2018 · CA · contact PI
Epidemiologic Study of Hepatocellular Carcinoma in the US$1,460,631
R01 · FY2015 · CA · contact PI
Epidemiologic Study of Hepatocellular Carcinoma in the US$1,068,256
R01 · FY2014 · CA · contact PI
Epidemiologic Study of Hepatocellular Carcinoma in the US$276,373
R01 · FY2013 · CA · contact PI
Epidemiologic Study of Hepatocellular Carcinoma in the US$1,059,509
R01 · FY2012 · CA · contact PI
Epidemiologic Study of Hepatocellular Carcinoma in the US$537,816
R01 · FY2011 · CA · contact PI
Epidemiologic Study of Hepatocellular Carcinoma in the US$1,310,686
R01 · FY2010 · CA · contact PI
Role of Genetic and Lifestyle Interplay in Uterus Cancer$582,463
R01 · FY2007 · CA · contact PI
Role of Genetic and Lifestyle Interplay in Uterus Cancer$586,254
R01 · FY2006 · CA · contact PI
Role of Genetic and Lifestyle Interplay in Uterus Cancer$610,866
R01 · FY2005 · CA
Role of Genetic and Lifestyle Interplay in Uterus Cancer$619,485
R01 · FY2004 · CA
DNA Methylation, Aging, and Prostate Cancer Risk$245,250
R01 · FY2004 · AG
Role of Genetic and Lifestyle Interplay in Uterus Cancer$627,017
R01 · FY2003 · CA
DNA Methylation, Aging, and Prostate Cancer Risk$245,250
R01 · FY2003 · AG
DNA Methylation, Aging, and Prostate Cancer Risk$227,470
R01 · FY2002 · AG
ESTROGEN AND INSULIN LIKE GROWTH FACTORS IN BREAST CANCE$57,225
R03 · FY2000 · CA
ESTROGEN AND INSULIN LIKE GROWTH FACTORS IN BREAST CANCE$24,195
R03 · FY2000 · CA